Advertisement

Annals of Surgical Oncology

, Volume 26, Issue 1, pp 310–311 | Cite as

Reply to “Multicentric Ipsilateral Invasive Breast Carcinomas Might Have Higher 21-Gene Recurrence Score Compared with Multifocal Ipsilateral Invasive Breast Carcinomas”

  • Anne GrabenstetterEmail author
  • Edi Brogi
  • Joanne Chou
  • Monica Morrow
  • Maura Dickler
  • Larry Norton
  • Hannah Wen
Breast Oncology
  • 58 Downloads

References

  1. 1.
    Carpenter S, Fraser J, Fleming M, Gray R, Halyard M, Pockaj B. Optimal treatment of multiple ipsilateral primary breast cancers. Am J Surg. 2008;196(4):530–536.CrossRefGoogle Scholar
  2. 2.
    Vlastos G, Rubio IT, Mirza NQ, et al. Impact of multicentricity on clinical outcome in patients with T1-2, N0-1, M0 breast cancer. Ann Surg Oncol. 2000;7(8):581–587.CrossRefGoogle Scholar
  3. 3.
    Lynch SP, Lei X, Chavez-MacGregor M, et al. Multifocality and multicentricity in breast cancer and survival outcomes. Ann Oncol. 2012;23(12):3063–3069.CrossRefGoogle Scholar
  4. 4.
    Kanumuri P, Hayse B, Killelea BK, Chagpar AB, Horowitz NR, Lannin DR. Characteristics of multifocal and multicentric breast cancers. Ann Surg Oncol. 2015;22(8):2475–2482.CrossRefGoogle Scholar
  5. 5.
    Vera-Badillo FE, Napoleone M, Ocana A, et al. Effect of multifocality and multicentricity on outcome in early stage breast cancer: a systematic review and meta-analysis. Breast Cancer Res Treat. 2014;146(2):235–244.CrossRefGoogle Scholar
  6. 6.
    Amin M, Edge S, Green F, et al. (eds). AJCC cancer staging manual. 8th ed. Chicago, IL: AJCC (2017).Google Scholar
  7. 7.
    Buggi F, Folli S, Curcio A, et al. Multicentric/multifocal breast cancer with a single histotype: is the biological characterization of all individual foci justified? Ann Oncol. 2012;23(8):2042–2046.CrossRefGoogle Scholar
  8. 8.
    Dawson PJ, Baekey PA, Clark RA. Mechanisms of multifocal breast cancer: an immunocytochemical study. Hum Pathol. 1995;26(9):965–969.CrossRefGoogle Scholar
  9. 9.
    Choi Y, Kim EJ, Seol H, et al. The hormone receptor, human epidermal growth factor receptor 2, and molecular subtype status of individual tumor foci in multifocal/multicentric invasive ductal carcinoma of breast. Hum Pathol. 2012;43(1):48–55.CrossRefGoogle Scholar
  10. 10.
    Middleton LP, Vlastos G, Mirza NQ, Eva S, Sahin AA. Multicentric mammary carcinoma: evidence of monoclonal proliferation. Cancer. 2002;94(7):1910–1916.CrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2018

Authors and Affiliations

  • Anne Grabenstetter
    • 1
    Email author
  • Edi Brogi
    • 1
  • Joanne Chou
    • 2
  • Monica Morrow
    • 3
  • Maura Dickler
    • 4
  • Larry Norton
    • 5
  • Hannah Wen
    • 1
  1. 1.Department of PathologyMemorial Sloan Kettering Cancer CenterNew YorkUSA
  2. 2.Department of Epidemiology and BiostatisticsMemorial Sloan-KetteringNew YorkUSA
  3. 3.Department of SurgeryMemorial Sloan-Kettering Cancer CenterNew YorkUSA
  4. 4.Lilly Oncology, Eli Lilly and CompanyNew YorkUSA
  5. 5.Department of MedicineMemorial Sloan Kettering Cancer CenterNew YorkUSA

Personalised recommendations